Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission
Glutamic acid decarboxylase of 65 kDa (GAD65) antibodies have been reported in a variety of neurological disorders such as stiff-person syndrome (SPS), sporadic ataxia and some cases of epilepsy. Since the target is believed to be the cytoplasmic enzyme GAD65, the key enzyme of γ-aminobutyric acid (...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Frontiers Media S.A.
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870265/ |